Patents by Inventor Virginia Rivero Buceta

Virginia Rivero Buceta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10208056
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3 R4, R5, R6, R7a and R7b have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. CDK8 and/or Haspin kinase) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.
    Type: Grant
    Filed: August 25, 2016
    Date of Patent: February 19, 2019
    Assignee: FUNDACIÓN DEL SECTOR PÚBLICO ESTATAL CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS CARLOS III (F.S.P. CNIO)
    Inventors: Joaquín Pastor Fernández, Sonia Martínez González, Carmen Blanco-Aparicio, Ana Isabel Hernández Higueras, Cristina Ana Gómez De La Oliva, Virginia Rivero Buceta, Rosario Concepción Riesco Fagundo
  • Publication number: 20180244687
    Abstract: There is provided compounds of formula I, wherein R1, R2, R3 R4, R5, R6, R7a and R7b have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. CDK8 and/or Haspin kinase) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.
    Type: Application
    Filed: August 25, 2016
    Publication date: August 30, 2018
    Inventors: Joaquín PASTOR FERNÁNDEZ, Sonia MARTÍNEZ GONZÁLEZ, Carmen BLANCO-APARICIO, Ana Isabel HERNÁNDEZ HIGUERAS, Cristina Ana GÓMEZ DE LA OLIVA, Virginia RIVERO BUCETA, Rosario Concepción RIESCO FAGUNDO
  • Publication number: 20130065883
    Abstract: There is provided compounds of formula (I), wherein R1, R2, R3 and R4 have meanings given in the description, and pharmaceutically-acceptable esters, amides, solvates or salts thereof, which compounds are useful in the treatment of diseases in which inhibition of a protein or lipid kinase (e.g. a PIM family kinase, such as PIM-1, PIM-2 and/or PIM-3, and/or Flt3) is desired and/or required, and particularly in the treatment of cancer or a proliferative disease.
    Type: Application
    Filed: February 18, 2011
    Publication date: March 14, 2013
    Applicant: Centro Nacional de Investigaceiones Oncologicas (CNIO)
    Inventors: Joaquin Pastor Fernández, Julen Oyarzabal Santamarina, Carl-Gustaf Pierre Saluste, Carmen Blanco Aparicio, Rosa Maria Alvarez Escobar, Virginia Rivero Buceta